| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.21 | 0.5 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.15 | 0.6 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.14 | 0.009 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |